Delivery Order SPE2DB25D3012-SPE2DB25FWYBQ

Award Date 6/17/25
Potential Completion Date 6/18/25
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,276.47, is for the delivery of "REFRESH PLUS 0.5% EYE DROPS 30S" with a completion date of June 6, 2025. The contract is not set-aside and was awarded on June 5, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $12,546.82 firm fixed-price contract is for the supply of REFRESH PLUS 0.5% EYE DROPS 30S, a medical product, with a completion date of May 28, 2025. The contract is not set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for $14,602.73. The contract is for the supply of "REFRESH PLUS 0.5% EYE DROPS 30S", a medical product, on a firm fixed price basis. The contract has a period of performance through May 31, 2024 and was not set aside for any specific business type. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,499.95, is for the supply of REFRESH PLUS 0.5% EYE DROPS 30S, a pharmaceutical product. The contract is a firm fixed-price delivery order, with a completion date of January 29, 2025. The contract is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite...
This $1,093.42 firm fixed-price delivery order was awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The order is for the supply of 4,561,837,935 units of REFRESH PLUS 0.5% EYE DROPS UD 50S, a prescription ophthalmic product, with a period of performance ending on August 18, 2023. This order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide REFRESH PLUS 0.5% EYE DROPS UD 70S. The delivery order, with a potential value of $1,368.90, has a completion date of February 2, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor and does not have any set-aside designation for this contract. This delivery...
This is a firm fixed price delivery order awarded to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical company Amerisourcebergen Corporation, by the Defense Logistics Agency (DLA) Troop Support Medical. The order is for the supply of "REFRESH PLUS 0.5% EYE DROPS 30S," a pharmaceutical product. The delivery order has a ceiling value of $1,194.72 and a period of performance through April 4, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,690.84, is for the delivery of "REFRESH PLUS 0.5% EYE DROPS 30S" medical supplies. The award is a Firm Fixed Price contract with an ultimate completion date of December 15, 2023. This Delivery Order is placed against Amerisourcebergen's existing Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,235.61, is for the delivery of REFRESH PLUS 0.5% EYE DROPS 30S, a pharmaceutical product. The contract is a firm fixed-price delivery order, with an ultimate completion date of April 10, 2025. The contract was not set aside for any specific business category. AmerisourceBergen Drug Corp...
This is a $1,595.52 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution company. The contract is for the supply of "REFRESH PLUS 0.5% EYE DROPS UD 50S", a type of prescription eye drops. The contract has a completion date of July 18, 2024 and does not utilize a set-aside designation. As a leading supplier of pharmaceutical and medical products to the federal government, AmerisourceBergen holds...
  • SPE2DB25D3012
    Indefinite Delivery Contract
  • SPE2DB25D3012-SPE2DB25FWYBQ
    Delivery Order

This is a Firm Fixed Price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,088.64, is for the delivery of REFRESH PLUS 0.5% EYE DROPS 30S. The contract has an ultimate completion date of June 18, 2025 and is not set aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This delivery order is part of the company's broader role as a critical vendor supporting federal medical procurement needs, particularly for military and veteran healthcare systems.

Generated 9/16/25, 9:57 AM